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Imaging of hip in osteoarthritis (OA) has seen considerable progress in the past decade, with the
introduction of new techniques that may be more sensitive to structural disease changes. The purpose of
this expert opinion, consensus driven recommendation is to provide detail on how to apply hip imaging
in disease modifying clinical trials. It includes information on acquisition methods/techniques (including
guidance on positioning for radiography, sequence/protocol recommendations/hardware for magnetic
resonance imaging (MRI)); commonly encountered problems (including positioning, hardware and coil
failures, artifacts associated with various MRI sequences); quality assurance/control procedures; mea-
surement methods; measurement performance (reliability, responsiveness, and validity); recommen-
dations for trials; and research recommendations.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Recent use of imaging in the evaluation of progression of hip
osteoarthritis (OA) has greatly increased. The previous guidelines
for imaging of the hip in clinical trials published in 1995 included
recommendations for imaging with a predominant focus on: G.E. Gold, Departments of
Stanford University, Stanford,
ternational. Published by Elsevier Lradiography (consistent with the era) with some detail in the
appendices on methods of acquiring radiographs and use of
magnetic resonance imaging (MRI)1. There were little if any de-
tails on different imaging methods available, pitfalls inherent to
each modality, or performance metrics of different imaging
markers.
The purpose of this expert opinion, consensus driven recom-
mendation is to provide details to researchers involved in disease
modifying OA clinical trials on how one might use and apply this
knowledge when using hip imaging assessments. It includes in-
formation on acquisition methods/techniques (including guidancetd. All rights reserved.
Table II
Recommendations for Clinical Trials: Average strength of recommendation from
the 12 persons on the working group who responded to the survey. The response
scale ranged from 0 (don't recommend) to 100 (strongly recommend)
Radiography Strength of
recommendation
(range 0e100)#
Radiographs of the hip should be done in supine
position for comfort of the subject rather than
weight-bearing
53
Scoring of hip OA on radiographs is best done with KL
grades or the OARSI Atlas
85
Automated methods for assessing parameters of JSW
offer promise of improved precision and therefore
improved responsiveness.
64
Radiographic JSW is still a recommended option for
trials of structure modiﬁcation, with the
understanding that the construct represents a
number of pathologies and trial duration may be
long.
60
MRI
Using MRI it is possible to accurately and feasibly
measure change in cartilage morphometry over 12
e18 months for hip OA and we recommend the use
of MRI for assessing cartilage morphometry in trials
of OA structure modiﬁcation.
63
Rather than try to assess hip cartilage morphometry
with MRI, we are better off at the current time
recommending semi-quantitative evaluation.
61
Structure modiﬁcation should be considered in a
broader context than that of cartilage alone. Since
MRI has the capacity to image the other tissues,
further work is needed on the quantiﬁcation and
predictive validity of non-cartilage MRI pathologies
The performance metrics of non-cartilage MRI
features have not been extensively studied but there
is a rapidly emerging literature in this ﬁeld.
82
MRI is now recommended for clinical trials in terms of
semi-quantitative scoring.
75
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tions/hardware for MRI); commonly encountered problems
(including positioning, hardware and coil failures, artifacts associ-
ated with various MRI sequences); quality assurance/control pro-
cedures; measurement methods; measurement performance
(reliability, responsiveness, and validity); recommendations for
trials; and research recommendations.
Methods
This review began with a search of PubMed using terms of
osteoarthritis, hip, and imaging.
We also conducted general searches for manuscripts covering
general randomized controlled trial (RCT) implementation
methods, covering each of the sub-topics below; from this litera-
ture we identiﬁed key study frameworks, designs and methods, as
well as other manuscripts of high relevance. Authors communi-
cated via a series of teleconferences and email correspondence to
identify additional topics and manuscripts for inclusion and to
develop and reach concurrence on a set of recommended principles
for inclusion of hip imaging methods in OA implementation trials.
Authors of this review included multiple experts familiar with
different approaches for imaging of the hip joint, including radi-
ologists, rheumatologists, and engineers. Final recommendations
(Tables II and III) were obtained by averaging the responses to a
survey among the 12 authors for the strength of recommendation
from 0 to 100.
Acquisition methods and techniques
Radiography
Introduction
Radiography is commonly used to evaluate patients with hip
OA. Radiography is widely available, inexpensive, and easy to
obtain, and interpretation of the radiographs is relatively simple
when compared to more sophisticated imaging modalities such as
MRI that depict more tissues with more types of available
contrast. Radiography can be used to measure radiographic joint
space width (JSW) and thereby to indirectly assess cartilage
thickness. In fact, joint space narrowing (JSN) on radiographs is
the only outcome measure recommended by the United States
Food and Drug Administration for use in OA clinical trials at pre-
sent. However, the limitation of radiography is that it can only
assess bone abnormalities such as osteophytes, subchondral cysts,Table I
Intra-observer and inter-observer variabilities of radiographic hip measurements
Article Number of subjects Acquisition
Lequesne et al.77 30 Supine
Maheu et al.16 50 Standing
Okano et al.10 162 Standing and
Supine
Conrozier et al.9 50 Standing
Nishii et al.15 156 Supinesclerosis, cortical irregularity, fracture and deformity. Radiog-
raphy cannot directly evaluate articular cartilage or assess other
non-calciﬁed joint structures including the labrum, synovium,
ligaments, tendons or bone marrow lesions (BMLs), all of which
can be sources of pain and possibly cause further damage to other
structures in OA. Furthermore, since radiography is a projection
technique, variability in positioning and superimposition of
overlying structures can obscure joint abnormalities, and
morphological distortion and magniﬁcation can complicate
quantitative measurements.Intra-observer variability Inter-observer variability
Observer1:
SD ¼ 0.26/ICC ¼ 0.90/LoA: [0.90; 0.55]
Observer2:
SD ¼ 0.33/ICC ¼ 0.77/LoA: [1.09; 0.74]
ICC ¼ 0.78
Manual reading
Observer1:
SD ¼ 0.25/ICC ¼ 0.96/LoA: [0.49; 0.51]
Observer2:
SD ¼ 0.15/ICC ¼ 0.98/LoA: [0.29; 0.31]
SD ¼ 0.39/ICC ¼ 0.88
SD ¼ 0.13 mm/CR ¼ 0.26 mm NA
Computer assisted reading
Observer1:
SD ¼ 0.13/ICC ¼ 0.96
Observer2:
SD ¼ 0.33/ICC ¼ 0.88
SD ¼ 0.31 mm
ICC ¼ 0.98
SD ¼ 0.140 mm/ICC ¼ 0.993 SD ¼ 0.248 mm/ICC ¼ 0.979
Table III
Recommendations for RESEARCH: Average strength of recommendation from the
12 persons on the working group who responded to the survey. The response scale
ranged from 0 (don't recommend) to 100 (strongly recommend)
General comments Strength of
recommendation
(range 0e100)#
Evaluation of age dependence of structural changes
(cartilage thickness and others) due to mechanical
stress in different age groups.
74
Conventional radiography
For joint space width, measurement performance
(reliability and responsiveness) dependency on
projection technique, dependency on axial loading
studies need to be done
71
For bony changes (osteophytes, erosions, cysts,
attrition) dependency of reproducibility on
projection technique needs study
74
MRI
Comparison between quantitative cartilage volume/
thickness with semi-quantitative scoring such as
HOAMS and SHOMRI should be performed.
74
Further investigation should also be done for
compositional MR methods such as T2 mapping and
T1rho to ﬁnd correlations between macro-and
microstructure changes in the hip joint.
71
Further investigation should be done for MRI
assessment of femoroacetabular impingement and
its potential relationship to the onset of hip OA
78
A correlation with clinical scores, clinical importance of
individual variables in the semi-quantitative scoring
systems as well as with quantitative values of the
compositional MR techniques should be performed.
88
Develop and appraise methods that will allow
qualitative (semi-quantitative) measures to be
quantitatively assessed as well as development of
semi-automated to fully automated measures.
78
Improved detection, quantiﬁcation and measurement
performance of structural, compositional changes of
hyaline and ﬁbrocartilage using MRI.
67
Development of semi-quantitative and quantitative as
well as fully automated evaluation of inﬂammatory
changes of the synovium.
80
Clinical validation of MRI methods and techniques in
general eWhat is their ability to predict real hip
replacement?
90
Fig. 1. AP supine radiograph of the pelvis. Focus to ﬁlm distance was approximately
100 cm, and digital detector was used.
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The orientation of the acetabulum relative to the AP X-ray beam
and/or tomographic images does not follow one of the three
orthogonal planes in space: In a standing position, both anterior
superior iliac spines and the pubic symphysis are all located in a
coronal/frontal plane (Fig. 1). The vector normal to the “entrance”
plane of the acetabulum, however, is oriented 24.3 ± 4.7 toward
anterior (in the axial/transverse plane) and 40.2 ± 4.3 towards
inferior (in the coronal/frontal plane)2. The articular cartilage sur-
face does not cover the entire acetabulum, but assumes the form of
a horseshoe (the lunate surface), excluding the acetabular fossa3.
Different parts of the lunate surface are commonly addressed as the
acetabular roof (top), anterior horn, and posterior horn. The mean
cartilage thickness of the lunate surface is 1.3 mm in the acetabu-
lum, and 1.4 mm in the femoral head3. The maximum cartilage
thickness in the acetabulumwas reported to be located ventrally in
the acetabular roof, at the outer rim of the lunate surface.
The inferior outlet of the acetabular fossa, i.e., the incisura
acetabuli, displays a 20.0 ± 6.0 ventral deviation from inferior in
the sagittal plane2, and is bridged by the transverse acetabular
ligament (TAL). Ventrally, the ﬁbers of the TAL insert close to the
labrum a ﬁbrocartilage that entirely surrounds the acetabulum,
whereas dorsally, the TAL inserts at the bone below the posteriorhorn, where it is continuous with the periosteum and the joint
capsule4.
Radiography: positioning, and image acquisition orientations
A hip radiographic study commonly consists of an ante-
roposterior (AP) and either a cross table or externally rotated frog-
leg lateral view. The hip should be internally rotated for the AP
radiograph. For the lateral projection, the patient's hip should be
ﬂexed and externally rotated with the X-ray beam directed antero-
posteriorly. Bone landmarks are helpful to determine adequacy of
the AP and lateral projections. On the AP radiograph the greater and
lesser trochanter should be clearly deﬁned and the greater
trochanter should not overlap the femoral neck. The calcar femoris
should be visible and there should be little overlap between the
anterior and posterior margins of the femoral head-neck junction.
The most common error is external rotation, but excessive internal
rotation should also be avoided, as both can impact measurements
of JSW. In the context of clinical trials a Lesquesne's view (also
called false proﬁle)5 might be helpful to assess the JSW and capture
early signs of OA. Lesquesne's view is an oblique view of the edge of
the acetabulum, to diagnose OA affecting the anterior part of the
joint and to measure the anterior coverage of the femoral head. For
this view the patient is standing with the affected hip on the
cassette, the ipsilateral foot parallel to the cassette and the pelvis
rotated 65 from the plane of the cassette. The beam should be
centered on the femoral head perpendicular to the cassette.
It is vital that the speciﬁc techniques used to acquire and
interpret radiographs are standardized when evaluating patients
with hip OA in multicenter or comparative research studies. All AP
radiographs should be obtained with digital detector systems and
low dose exposure using a focus to ﬁlm distance of approximately
100 cm1. Radiographs may be acquired with the patient in a
standing or supine position (Fig. 2). While standing radiographs
may theoretically provide more accurate estimation of cartilage
thickness by exposing cartilage to the same loading and hydration
conditions which occur during weight-bearing activity6, accurate
measurements of hip JSW can be obtained on both on standing and
supine radiographs7e9. Standing radiographs have been shown to
providemore accurate assessment of JSW in patients with dysplasia
of the hip10. In obese patients, abdominal pannus may project over
the hip joint in the standing position and limit penetration of the X-
ray beam with the effect of reduced image quality7. Longitudinal
studies should not switch between views on different subjects or at
different time points.
Fig. 2. (a) Supine and (b) weight-bearing radiographs of the hip. Note the weight bearing view has overlying pannus that degrades image quality. Either image could be used to
measure joint space width.
G.E. Gold et al. / Osteoarthritis and Cartilage 23 (2015) 716e731 719If the subject is standing, both feet should be internally rotated
by 1011. Foot maps aid reproducibility of positioning which is
especially important in longitudinal studies. If the subject is supine,
the X-ray beam should be perpendicular to the table and centered
on the superior aspect of the symphysis pubis, and the feet should
be internally rotated 15e20 to generate force on the articular
surface, obviating the need for standing weight-bearing acquisi-
tion1. Auleley recommended use of a positioning device to ensure
the femur was rotated at a standard 15 of internal rotation7. All
other papers measuring hip JSW in a supine position acquired
images without use of a positioning device and with the femur
rotated between 5 of external rotation and 15 of internal
rotation12e15. A recent paper by Maheu et al. concluded that front
AP pelvic or front hip view of the target hip should be preferred16.MRI
Introduction
MRI assessment of the hip is challenging for several reasons:
1. The hip joint is deep within the body and it is not in the iso-
center of the magnet.
2. The cartilage is very thin and differentiation between the
acetabular and femoral cartilage layer is difﬁcult2.
3. Homogeneous fat suppression with larger ﬁeld of view (FOV) is
problematic below 3 T.
4. The hip is a spherical joint and as a consequence partial volume
effects are stronger than in the knee joint.
5. Surface coils need to be used which allow high signal and high
resolution imaging, but there are no dedicated hip coils17,18.
Image acquisition
Given the complex geometry of the hip joint, standardizedMRI of
the hip should be performed in multiple planes of imaging. For im-
aging of tissue morphology (thickness, volume, position), the best
orientations are coronal, sagittal and oblique axial. Coronal and
sagittal sequences allow good visualization of the cartilage and the
labrum18, while oblique axial sequences provide information on
head-neck deformity,which is seenwith CAM type femoroacetabular
impingement19. Axial or radial images can also be used for assess-
ment of the femoral head-neck junction anatomy. For quantitativedetermination of the hip cartilage, sagittal images avoid the acetab-
ular fossa which is mostly covered by synovial tissue20. Radial ac-
quisitions passing through the center of the femoral neck and the
fovea allow for more direct tangential assessment of cartilage and
labral integrity, reducing partial volume averaging and enhancing
delineation between femoral and acetabular cartilage surfaces21.
However, radial imaging suffers from signal loss at the center due to
saturation fromdifferent slices if acquired in 2D. Use of coronal, axial,
and sagittal 3D sequences with near isotropic resolution has the
potential to overcome limitations of radial acquisitions22.
Accurate and reproducible assessment of the hip may be per-
formed at either 1.5 or 3.0 T ﬁeld strength23. However, 3.0 T im-
aging systems do provide better signal-to-noise ratio (SNR) that
allows higher resolution images to be acquired in the same scan
time without a reduction in image quality24. Several coils can be
used for MRI of the hip including: a cardiac surface coil, a ﬂexible
body coil21, or one of several new multiple channel ﬂexible coils
that provide high signal to noise. Comfortable positioning is
indispensable to avoid motion artifacts, which adversely impact
image quality. In order to achieve high resolution and signal to
noise in a limited examination time, one hip should be examined at
a time with a dedicated coil17. It should be noted, however, that
small FOVs may lead to aliasing or wrap around artifacts, and phase
oversampling may not completely resolve these issues. MRI
assessment of the hip may be impacted by rotation of the femoral
neck, and reproducible positioning of the lower extremity with
internal rotation will improve imaging during longitudinal studies.Image contrast
MRI protocols of the hip typically use two-dimensional fast
spin-echo sequences with intermediate-weighted and T2-
weighted contrast with fat suppression or short tau inversion re-
covery (STIR), which are effective in assessing occult fracture or
unsuspected intra-pelvic pathology (Fig. 3). Femoral anteversion
may be assessed using low-resolution axial images acquired
through both distal femora in combination with standard axial
images of the pelvis including both hip joints. This may eliminate
the need for ionizing radiation and version assessment using
computerized tomography (CT)25.
Some authors have advocated the use of MR arthrography of the
hip, this being more invasive with potential risks of infection, nerve
Fig. 3. Standard MRI examination of the hip with two-dimensional fast or turbo spin-echo sequences. (a) Axial intermediate weighted MRI without fat suppression. (b) Axial T2-
weighted MRI with fat suppression. (c) Coronal intermediate weighted MRI with fat suppression. (d) Coronal T1-weighted MRI without fat suppression. (e) Sagittal intermediate-
weighted MRI with fat suppression. All relevant anatomy (bone, cartilage, joint ﬂuid, labrum) can be evaluated on these images.
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MR arthrography may be useful in the clinical setting for joint
distention and intra-articular nerve block for diagnosis. The deci-
sion whether the hip is imaged using MR arthrography or high-
resolution non-contrast MRI should be based upon the personal
experience of the referring physician and the musculoskeletal
radiologist. In a clinical trial setting MR arthrography may be
challenging to pursue due to reasons of difﬁculty obtaining IRB
approval, selection bias of patients, and the invasive nature and
associated risks of hip joint injection as described above, as well as
operational challenges.
Non-contrast MR protocols for evaluating the hip should ideally
take advantage of the inherent magnetization transfer effect in
articular cartilage, allowing for differential contrast between in-
termediate signal intensity cartilage, low signal intensity labrum,
and high signal intensity subchondral bone marrow26. Fat sup-
pression techniques may be employed to optimize the dynamic
contrast range of the image and to reduce chemical shift at the
bone-cartilage interface27. Furthermore, fat-suppressed sequences
are highly sensitive to bone marrow abnormalities that may be
missed when applying only non-fat-suppressed imaging. Use of a
wider receiver bandwidth on non-fat suppressed images mini-
mizes chemical shift artifact and decreases inter-echo spacing,
reducing scan times and artifact. Increased receiver bandwidth
comes at the cost of SNR. MR protocols should use echo times be-
tween 30 ms and 60 ms. Slice thicknesses of 2.0e2.5 mm with no
gap between slices are most effective for detecting cartilage and
labral pathology. Oversampling in the frequency direction with a
512 matrix, combined with 320e384 phase encoding steps, allows
for a high in-plane resolution of 0.30e0.35 mmwhich is especiallyimportant for identifying subtle labral tears and cartilage defects
and delamination26.
Three-dimensional MRI
Three-dimensional gradient-echo and fast spin-echo sequences
(Fig. 4) are useful in longitudinal studies for measuring cartilage
thickness change in the hip joint28. However, three-dimensional
imaging can be more susceptible to artifacts such as motion due
to longer scan times and phase wrap. Tissue contrast in three-
dimensional gradient echo sequences limits the evaluation of the
labrum, ligaments and tendon insertions. Quantitative assessment
of hip cartilage is challenging due to the spherical surface geometry
of the femoral head and acetabulum, the thin cartilage, and the
inherent difﬁculty in differentiating acetabular from femoral
cartilage. However, with use of high ﬁeld strength scanners and
multi-channel coils, three-dimensional images of articular cartilage
with 0.3  0.3 mm in-plane spatial resolution and 1.5 mm slice
thickness can be acquired in relatively short imaging times29.
Quantitative assessment is best performed in a standardized
fashion, dividing the articular surface into zones for regional
analysis. Intra-articular contrast and traction may allow separation
of acetabular from femoral head cartilage, but both are challenging
for clinical trials30. MR sequences that provide bright (hyperin-
tense) joint ﬂuid may have the best chance of delineating the layers
consistently, or use of radial two-dimensional approaches21.
MRI of cartilage composition
Various compositional MR techniques have been used to eval-
uate hip cartilage such as delayed gadolinium enhanced imaging
(dGEMRIC)31,32, T2-33,34, and T1rhomapping35. The use of dGEMRIC
Fig. 4. Reformations from an axial 0.8 mm isotropic 3D fast spin-echo acquisition at 3 T. (a) Coronal reformat, 3 mm slice. (b) Sagittal reformat, 3 mm slice.
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content of cartilage, but is less popular due the relatively long (1- to
2-h) delay between injection and imaging, and the potential risk of
contrast reactions36e38. The use of T2 or T1rho mapping (Fig. 5) for
assessing collagen ultra-structure39 and proteoglycan
depletion40e43 respectively obviates the need for contrast, but T2
and T1rho relaxation times of cartilage are non-speciﬁc which may
reﬂect multiple biological (compositional) changes that occur with
cartilage pathology44,45, mechanical loading46, and orientation of
cartilage relative to the main magnetic ﬁeld47,48. Thus, in-
terpretations of changes in T2 and T1rho relaxation time of carti-
lage in longitudinal studies are difﬁcult. Validation of these
techniques is still ongoing and recommendations on which tech-
nique is best suited for application in a clinical trial setting are
premature.Computed tomography/arthrography/ultrasound
Computed tomography (CT) can be used in the hip joint to
provide a 3D assessment of bone anatomy, and is useful in mea-
surement of FAI for pre-surgical planning (Fig. 6). CT is a widely
available modality that can rapidly provide information on the
bony anatomy with high spatial resolution; further images can be
automatically segmented to provide this 3D information. Without
intra-articular contrast, however, CT provides little information on
the cartilage, labrum, and soft tissues of the joint. Also, because CT
of the hip exposes sensitive organs with ionizing radiation, theFig. 5. T1rho (left) and T2 (right) color maps of the hip in a healthy volunteer, for evaluatio
with proteoglycan content.
Reproduced with permission from John Wiley and Sons (license number 3603340482801;small risk of potential induction of cancer in subjects in larger
clinical trials should be considered. Ultrasound may be used to
detect hip joint effusion but is not commonly used in hip OA clinical
trials.Commonly encountered problems: positioning, hardware and
coil failures, sequences/artifacts
Commonly encountered problems in radiography
Subtle positional changes of the hip, which may be due to pain
or secondary to OA, may alter the measured JSW on AP abdominal
and pelvic radiographs14. The inﬂuence of joint positioning and
radiographic procedures was also analyzed7 and it was found that
modifying the X-ray beam and foot rotation increases variability in
JSW measurements. One study reported that 15 of adduction or
30 of ﬂexion of the hip resulted in apparent widening of the hip
JSW, whereas hip abduction caused reductions in JSW. Minor hip
ﬂexion (<15); however, did not seem to inﬂuence the JSW mea-
surement. These patterns were reproduced at superior-lateral, su-
perior-medial, and superior-intermediate locations of hip JSW
measurement. Assessment at the point of maximal narrowing
appeared to be inﬂuenced less by positional changes than the
average of the three deﬁned-site measurements14 or other mea-
surement locations.n of cartilage matrix properties. T2 is correlated with collagen organization, and T1rho
J Magn Reson Imaging. 2015 Mar;41(3):doi: 10.1002/jmri.24868
Fig. 6. (a) Coronal reformation of computed tomography study of the pelvis, demonstrating os acetabuli (arrow). (b) Three-dimensional shaded-surface display of the same hip,
shown from a sagittal orientation. Arrows show the os acetabuli.
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Similar to other clinical trials utilizing imaging in OA, it is
important to consider the speciﬁc trial endpoints when deter-
mining the MRI protocol and the required ﬁeld strength of the MRI
unit. Regardless of whether the endpoints will be semi-quantitative
scores or quantitative measurements, to ensure reliable results the
imaging protocol must be deﬁned before the trial starts and com-
plied with by all clinical sites for the duration of the trial. All trial
sites must comply with the speciﬁed standardized imaging proto-
col. In addition, incoming data quality control needs to include
veriﬁcation of imaging parameters, including slice thickness and in-
plane resolution. To avoid future errors, and maximize the chance
of recalling subjects when necessary for re-imaging and retaining
them in the study, feedback to imaging sites needs to happen
quickly and on an ongoing basis.
Imaging planes and resolution
Imaging planes should be aligned in the anatomic coronal and
sagittal planes, with the option for additional special radial views
that can be used for assessment of the acetabular labrum. For
quantitative analysis of the cartilage, high resolution and high SNR
is required. Selection of an oblique axial imaging plane aligned with
the femoral neck can be used to assess the alpha angle. Although
thin slices are not considered to be as essential for semi-
quantitative scoring as for quantitative measurements of cartilage
thickness, thicker slices will make the detection of changes in all
scored parameters difﬁcult. This affects mostly scoring of cartilage
thickness and cartilage defects; small defects may seem to come
and go and changes in cartilage thickness are hard to see due to
partial volume effects and the relationship between the voxel size
and the size of the feature may change. However, thicker slices also
affect scoring of BMLs and even the amount of joint ﬂuid. For
reliable scoring results, especially for cartilage, slice thickness
should ideally be 2e3mm and should not exceed 3.5 mm and there
should be no gap between slices. However, researchers have to be
aware that thinner slices require longer acquisition times and result
in a loss of signal compared to thicker slices.
Quantitative cartilage imaging is more demanding for spatial
resolution, with slice thickness from 1.5 to 2 mm and in plane
resolution from 0.4  0.4 mm to 0.6  0.6 mm necessary to reliably
detect and follow small defects less than 5 mm2. In OA the pre-
sentation of cartilage loss can vary from enlargement of a single
defect to the thinning of cartilage over large areas, therefore a slice
thickness of 2e3 mm and in-plane resolution of 0.6  0.6 mm or
higher are recommended. In this context it is important to note that
quantitative analysis does not require isotropic resolution.Consistency of slice thickness is important in scoring change and
measuring cartilage thickness.
Imaging sequences
The goals of imaging sequences for quantitative cartilage anal-
ysis in the hip are similar to the knee joint. As such, they are
manufacturer-dependent as every manufacturer has a proprietary
approach to some type of fat suppressed/fat saturated/water
excited acquisition; either a 3D fast spin echo or some form of 3D
fast gradient echo sequence. All of those sequences have been
validated for imaging of cartilage22,49e52. Their ability to show the
boundaries between bone-cartilage, cartilageecartilage, cartilage-
degenerated meniscus, cartilage-inﬂamed synovium, and
cartilage-synovial ﬂuid varies. While selecting a sequence it is
important to ensure that the imaging parameters are selected so
that the visualization of those interfaces are optimally delineated,
particularly those with the greatest impact on study endpoint.
MRI for quantitative assessment of cartilage composition using
T2 and T1rho mapping has similar resolution dependencies as
quantitative imaging of cartilage thickness. Thick slices and low in-
plane resolution will limit detection to generalized changes while
preventing detection of local abnormalities and their progression.
For T2 measurements a practical slice thickness is 3 mm. There are
varying opinions of the number of echoes needed in the multi-echo
spin echo series for reliable T2 calculations, varying from two
echoes to 11 echoes53,54, as well as of the smallest reliable echoes55.
The practical issue is that the larger the number of echoes, the
smaller the number of slices that can be acquired, limiting
anatomical coverage of the hip with thin slices. Regardless of the
number of slices, however, assessments are only useful for com-
parison if the area covered and the imaging plane used are the same
from time point to time point.
The variability of T2 measurements between different manu-
facturers and different imaging units is a well-known confounding
factor. The effect of the variability can be minimized by using small,
standardized MRI phantoms with different T2 relaxation times,
which are positioned in the imaging FOV of the T2 series acquired
for each subject at each time point. This facilitates pooling of T2
data across multiple sites and equipment and veriﬁes possible
change between time points56. Imaging of the transverse relaxation
time using gradient echoes, T2*, has been studied in femo-
roacetabular impingement, but has not been validated in OA tri-
als57. At this time, T1rho sequences have not been validated for use
in OA trials; therefore, their use will be limited to provide only
experimental endpoints.
Since both quantitative and qualitative assessments may use fat-
suppressed/saturated sequences, inhomogeneous fat suppression
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due to ﬁeld inhomogeneity affects the qualitative measure-
ments58,59. Since the cartilage thickness changes over time are
relatively small geometric distortion can affect the reliability of the
results. The stability of ﬁeld homogeneity should be monitored by
scanning special uniformity and linearity phantoms at the start of
the study and periodically throughout60. Transmit/receive as well as
receive only coils, which are used for knee and hip imaging tend to
start failing slowly61. Therefore phantom scanning should monitor
coil performance throughout the study. Although of relatively rare
occurrence, signiﬁcant changes in imaging performance can be
caused by software or hardware upgrades of the scanner, or prob-
lems requiring a re-shim. Periodic phantom scanning can detect
these issues before too much study data has been potentially lost.
Commonly encountered problems in ultrasound and CT
Ultrasound may be used to assess joint effusion and synovitis. If
inﬂammation in the hip joint is an endpoint of a study, ultrasound
may be considered but is prone to operator dependence. Ultra-
sound is not routinely used in the evaluation of hip OA.
CT allows exquisite delineation of the bony structures but is
limited in assessment of soft tissue structures. If the bony anatomy
is an important endpoint, CT can be considered. Generally, thin
slices with high in-plane resolution should be obtained for refor-
mations and 3D models.
Quality assurance/control procedures
Quality assurance of hip radiography
For quality assurance in radiography, themost important aspect is
that images are acquired in a consistent manner for any subject in a
study evaluating longitudinal measurements. The choice of standing
or supine is less critical than consistency. Studies attempting to use
images obtained for another purpose, such as abdominal ﬁlms, show
less consistency in grading and measurement of hip JSW. In sum-
mary, antero-posterior radiographs of the pelvis that includes both
hips with feet rotated in 15e20 should be obtained utilizing a foot
map. There may be a slight advantage of weight bearing over
reclined position in more severely narrowed hips12, but in obese
subjects weight-bearing images can reduce image quality.
Quality assurance of hip MRI
To date no clinical trials have applied MRI for serial assessment
of the hip. MRI of the hip has drawn a lot of attention in recent years
due to its potential role of assessing joints of patients with femo-
roacetabular impingement and acetabular dysplasia, both a po-
tential risk for consequent hip OA and surgically treatable
condition62e64. In order to stratify patients that might potentially
beneﬁt from surgery, complex MRI protocols have been developed
to evaluate all intra- and periarticular structures such as the
labrum, cartilage, subchondral bone, and periarticular
tissues26,30,62e64. These protocols include 1.5 T and 3 TMRI systems,
the application of reformatted or primarily acquired radial se-
quences, the application of gadolinium-based contrast agents for
assessing cartilage matrix composition, and oblique planes along
different anatomical structures of the joint26,30,65,66.
While MRI is capable of visualizing extremely detailed anatomy
and pathology, the implementation of some of the above protocols
appears to be challenging due to complex requirements on the
technologist's side and lengthy exams that predispose to patients'
motion artifacts67,68. Advanced and complex protocols are chal-
lenging to implement when to be applied to large studies includingmultiple clinical sites. For whole joint assessment standard fast or
turbo spin-echo sequences using anatomic imaging planes have
proven sufﬁcient for achieving a reasonable reliability for the
different features assessed69. Further the deﬁnition of the outcome,
i.e., a single joint or both hips, is relevant to protocol development.
Acquisition of both sides, especially with the purpose of quantita-
tive assessment of cartilage, is much more time consuming and
prone to motion artifacts due to long acquisition time.
The same quality assurance measures that apply to the knee
joint also apply to the hip joint, including calibration markers
visible in the FOV for quantitative measurements and periodic
phantom calibration to ensure longitudinal repeatability.
Measurement methods e hip imaging
Radiography
Radiographic methods are mostly based on measurements of
JSW (quantitatively stated in mm) and the size of osteophytes.
Semi-quantitative methods have been used for several decades and
include the Kellgren and Lawrence (KL) grading70,71, the Croft
score72 and the OARSI scores of osteophytes and JSN base on the
Atlas73. The OARSI atlas does not deﬁne OA but grades different
features of hip OA and deﬁnes these by presenting image examples.
The main features are superior acetabular and femoral osteophytes,
inferior osteophytes as well as superior and medial JSN, which are
classiﬁed from 0 to 3. In addition subchondral cysts, subchondral
sclerosis and thickening of the medial femoral calcar (buttressing)
are differentiated.
KL grading differentiates 4 grades of hip OA: grade 1 (doubtful
OA), no narrowing of the joint space and possible osteophytes; grade
2 (mild OA), deﬁnite osteophytes, and possible JSN; grade 3 (mod-
erate OA), deﬁnite JSN, moderate osteophytes, some sclerosis and
cyst formation, and possible deformity of the femoral head and ac-
etabulum; and grade 4 (severe OA), complete loss of JSW with scle-
rosis and cysts, marked deformity of the femoral head and
acetabulum, and large osteophytes. Excellent inter-reader variability
has been reported in a recent studyof KL grades of thehip74. The Croft
score grades OA into ﬁve categories: grade 1, osteophytes only; grade
2, JSN only; grade 3, two of osteophytes, JSN, subchondral sclerosis,
and cyst formation; grade 4, three of the same features as above; and
grade 5, as in grade 4 but with deformity of the femoral head. A
previous study comparing both grading systems by intra-and inter-
observer variation found kappa values of around 0.6, which were
somewhat lower for the Croft score75. The same study showed higher
kappa scores for measuring reductions in JSW (kappa value ¼ 0.87).
Different quantitative measurements to assess JSW are
available76e78. A recent comparison of manual vs computed-
assisted JSW measurement over 3 years on pelvic radiographs,
front hip view and Lequesne's oblique view concluded that front AP
pelvic or front hip view of the target hip should be preferred. This
paper showed that the manual reading (using a 1/10 mm graded
magnifying glass) by a highly trained reader was more accurate and
sensitive to change than the computed-assisted measurement16.
Hip OAwas deﬁned on radiographs by aminimum JSW2.0 mm
and was found to be the simplest and most reproducible classiﬁ-
cation in long-term follow-up of patients with developmental hip
dysplasia and OA77,79. An alternative to JSW is to use 2D statistical
shape models (SSSMs)80,81 that may reduce the tendency of the
measurements to vary as a result of beam angle or positioning.
MRI
MRI based semi-quantitative measurements allow classifying a
large variety of tissues involved in OA such as cartilage
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abnormalities. Two semi-quantitative scoring systems have been
used to date; i.e., the hip osteoarthritis MRI scoring system (HOAMS)
score69 and the scoring hip osteoarthritis with MRI (SHOMRI)
score82. HOAMS is a whole-joint MRI score that incorporates 14
articular features including: cartilage morphology, subchondral
BMLs, subchondral cysts, osteophytes, acetabular labrum, synovitis
(whenever contrast-enhanced sequences were available), joint
effusion, loose bodies, attrition, dysplasia, trochanteric bursitis or
insertional tendonitis of the greater trochanter, labral hypertrophy,
paralabral cysts and herniation pits at the superior lateral femoral
neck69. Three of the features examined (cartilage morphology,
subarticular BMLs, subarticular cysts) related to the articular sur-
faces were subdivided into nine sub regions for cartilage evaluation,
in relation to their position on the articular surfaces, and 15 sub
regions for acetabular and femoral subchondral BMLs. The articular
cartilage surfaces of the acetabulum and femoral head were scored
together as a clear delineation of both surfaces is not possible on
standard non-arthrography 1.5 T MRI. The SHOMRI classiﬁcation
scores only eight features including articular cartilage loss, BML
pattern, subchondral cysts, labral abnormalities, loose bodies, joint
effusion and ligamentum teres abnormalities82,83. Ten sub regions
are used in evaluation of cartilage, BML pattern, and subchondral
cysts, four sub regions in the acetabulum and six in the femur.
The Hip Inﬂammation MRI Scoring System (HIMRISS) has also
been described but was designed only for active lesions (BML, sy-
novitis/effusion)84,85.
Cartilage biochemical composition of the hip has been quantiﬁed
with T220,33,86 and T2* relaxation time measurements87,
dGEMRIC31,32,66,88e96 and T1rho relaxation time measurements35.
An initial study95 found high reproducibility using dGEMRIC (ICC
range, 0.667e0.915) in young healthy subjects. Additional studies
applied dGEMRIC to the study of femoroacetabular
impingement96e98 and hip dysplasia66. Using T1rho and T2 a recent
study demonstrated regional variations in hip cartilage composition
and suggested that analysis based on local regions was more sen-
sitive than global measures in subjects with and without femo-
roacetabular impingement20. Overall it should be noted that most of
these studies analyzing quantitative MR parameters at the hip were
performed in small populations and targeted early changes mostly
in patients with femoroacetabular impingement (Fig. 7) and hip
dysplasia; these techniques at the hip are inherently challenging
because of the thin cartilage layer and required high resolution MRI.
Ultrasound and CT
Both Ultrasound and CT have a limited role in assessing OA and
are commonly used for evaluating synovitis and joint effusion
(ultrasound) or for fracture diagnosis (CT). CT provides detailed
information on osteophytes, subchondral sclerosis and JSN but is
not used as a standard technique for OA assessment. Also Nuclear
Medicine techniques are generally not used for measuring hip OA
although subchondral bone alterations may be characterized by
bone scintigraphy99 or 18F-ﬂuoride PET100.
Measurement performance: reliability, responsiveness,
validity
Radiography
Concurrent validity
Several studies showed cross-sectional relationship between
JSW and symptoms as reported in a relatively recent meta-anal-
ysis13. For example, in a population-based study including 3595
participants, it was shown that the presence of hip pain, ofmoderate and severe disability and, to a lesser extent, stiffness,
were associated with minimal JSW101. In another population-based
study of 3208 participants, a minimal JSW2 mmwas signiﬁcantly
associated with self-reported pain in or around the hip joint during
the previous 12 months102. Another study in 735 participants from
the Johnston County Osteoarthritis Project that took JSW mea-
surements at the ﬁrst follow-up, reported minimal JSW not to be
related to pain, but a minimal JSW <2.5 mm was found to be
associated with functional impairment103.
The same meta-analysis looked at longitudinal validity and only
found two articles with relationship between baseline symptoms
and subsequent JSW loss13. In the ﬁrst study of 458 patients in a 3-
year RCT, a baseline Lequesne's index > 10 was an independent
predictor of subsequent 1-year change in minimal
JSW  0.6 mm104. In the second study of 745 women aged over 65
with radiographic hip OA (936 hips), the JSW loss during follow-up
was greater in subjects with baseline hip pain105.
Table I provides the inter- and intra-observer variability of the
JSW from a number of studies evaluating the hip with manual and
semi-automated software. Reproducibility was poorer in the hip
than in the knee and even with semi-automated software about
25% of cases required operator intervention. Hip JSW loss amounts
to between 0.02 mm/yr5 and 0.09 mm/yr106 but speciﬁc subgroups
(about 15%) may display a more rapid progression of up to
0.42 ± 0.24 mm/yr106. Moreover, a high proportion of patients vary
and very few do not vary at all, over a 3-year period of time, which
means that the distribution of changes in JSW does not follow a
normal distribution, as shown in a recent structure-modifying
trial107.
If additional views of the hip joint are needed for a particular
study, then alternative positions, such as the Frog leg and/or Les-
quesne's position can be performed.
Predictive validity
When looking at the prediction of future JSW loss, a 3-year RCT
study in 458 patients demonstrated baseline minimal JSW
<2.0 mm was an independent predictor of 12 month radiological
progression104.
Regarding prediction of future JSW loss or future total hip
replacement (THR), a prospective cohort (mean follow-
up ¼ 6.6 ± 0.5 years), showed that baseline minimal JSW  2.5 mm
was a predictor of a JSW loss  1.0 mm or a THR11.
With respect to predicting THR, ﬁve studies showed a rela-
tionship between baseline JSWand later THR. In a 3-year RCT in 506
patients, the combination of a baseline minimal JSW <2 mm and
the rate of ﬁrst year change in minimal JSW was more strongly
associated with THR during the 2-year follow-up108. These same
patients were followed-up for an additional 2 years and the study
showed a decrease of minimal JSW of at least 0.2 mm during the
ﬁrst year predicted THR during the four following years and a
decrease of minimal JSW of at least 0.4 mm during the ﬁrst 2 years
predicted THR during the three following years109.
Responsiveness
In a recent meta-analysis, data on minimal JSW were extracted
from 11 articles (seven cohort studies, four RCTs). Minimal JSW was
assessed using a manual technique in four studies, and a computer-
based technique in seven. Themean sample sizewas 164. The overall
SRM was 0.66 (95% conﬁdential interval (95% CI) ¼ 0.41e0.91). The
responsiveness tended to be higher in observational studies
(SRM ¼ 0.83; 95%CI: 0.49, 1.16) than in RCTs (SRM ¼ 0.35; 95%CI:
0.12, 0.57). Responsiveness varied by method of measurement, with
greater responsiveness seen in studies using computer-based mea-
surement (SRM ¼ 1.12; 95%CI: 0.64, 1.59) compared to manual
measurement (SRM ¼ 0.47; 95%CI: 0.31, 0.62)13.
Fig. 7. T1-weighted fat-suppressed images from an MRI arthrogram in a subject with a history of femoroacetabular impingement. (a) Coronal image showing a labral tear (arrow).
(b) Sagittal image showing an anterior labral tear. (c) Oblique axial image for measurement of alpha angle.
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Improved inter-observer agreement (kappa value ¼ 0.87) on
radiography was obtained with minimum JSW (<2.0 mm). Inter-
observer agreement was moderate (kappa ¼ 0.55) for KL and
Croft grading, but kappa increased when the number of categories
was reduced from 5 to 3 (no OA, mild OA, and severe OA). The intra-
observer agreement was better than inter-observer agreement75.MRI
Reliability
Reliability for HOAMS was performed on a random subset of 15
cases with hip pain69. Weighted-kappa statistics as measure of
intra- and inter-observer reliability were as follows: Intra-reader
reliability for the different features ranged from 0.18 (cysts) to
0.85 (cartilage). Inter-reader reliability ranged between 0.15 (cysts)
and 0.85 (BMLs). For BMLs, synovitis/effusion, reliability of HOAMS
and HIMRISS were as follows: HIMRISS: ICCs of 0.52, 0.61, 0.7, and
0.58 for femoral BMLs, acetabular BMLs, effusion, and total scores;
HOAMS: ICCs of 0.52 and 0.46 for summed BMLs and synovitis in
with improvement of ICCs in the second exercise. Inter-reader
agreement for change scores was 0.81 (HIMRISS e femoral) and
0.71 (HOAMS summed) BMLs110.
Reliability for the SHOMRI score was analyzed in 72 subjects
with and without radiographic evidence of OA82. Intra- and inter-
reader intra-class correlation coefﬁcients ranged from 0.91 to
0.98. Intra-reader kappa values were between 0.65 and 0.79 with
lowest values obtained for paralabral cysts and highest values for
BMLs. Inter-reader kappa values were between 0.55 and 0.79 with
lowest values seen for effusion/synovitis and highest values for
intra-articular bodies.
In one study of cartilage volume4, intraobserver reliability was
assessed in 100 subjects on the same images with at least a 1-week
interval between measures. The coefﬁcient of variation (CV) was
2.5%. Interobserver reliability was assessed in 20 subjects, with a CV
of 4.4%.
An automated method for cartilage volume measurement21 has
also been tested. Acquisition was done on 1.5 T Siemens MRI
scanner using radial sequence. Cartilage volume/thickness varia-
tion of the implementation of the bone registration: femoral head
0.08% ± 0.04; acetabulum 0.05% ± 0.09. Intra-reader coefﬁcient
variation or the global and each sub region 0.942, P < 0.0001.
Inter-visit coefﬁcient variation: global 0.983, P < 0.0001; femoral
head 0.984, P < 0.0001; acetabulum 0.956, P < 0.0001; each
subregion 0.837, P < 0.005. Repeatability measurements wereroot mean square CV% for global 3%, femoral head 3.6%; acetabulum
5.6%. In a study by Mechlenburg et al., three different methods of
quantifying cartilage thickness measures fromMRI were compared
in subjects with hip dysplasia111. The authors concluded that a
radial acquisition might be the optimal one. As the cartilage surface
was intersected perpendicular so the partial volume effect was
avoided.
Responsiveness
Both HIMRISS and HOAMS showed moderate to high respon-
siveness and discrimination for synovitis and effusion110. Jaremko
et al. performed a recent systematic review where the authors
evaluated relevant features to be assessed including the ones
associated with inﬂammation (BMLs, synovitis/effusion), structural
damage (cartilage and labrum damage, subchondral cysts) and
deformities (dysplasia, CAM- or Pincer-impingement)84. However,
the sole parameter of validation for HOAMS and HIMRISS was
assessment of reliability, since neither one of these systems has
thus far been tested for responsiveness or validity regarding lon-
gitudinal clinical outcomes. There is a severe lack of data of
responsiveness of quantitative measures of hip OA for clinical trials.
Validity
The HOAMS scoring system69 showed a non-signiﬁcant trend
associated with hip pain. Compared to X-ray, HOAMS showed se-
vere cartilage damage (>3), P < 0.001 for trend, also BMLs, cysts,
synovitis (all signiﬁcant). When applying both HIMRISS and
HOAMS, a recent study demonstrated signiﬁcant associations be-
tween BMLs or synovitis scores with Western Ontario and
McMaster osteoarthritis index (WOMAC) pain scores at baseline110.
SHOMRI BML pattern and subchondral cysts scores showed a
signiﬁcant correlation with all three hip disability and osteoar-
thritis outcome score (HOOS) subscales (P range <0.001e0.01)82.
Articular cartilage and paralabral cyst scores correlated with
symptoms and activities of daily living (ADL) subscales (P range
0.01e0.05). Labrum scores also correlated with the symptom sub-
scale (P ¼ 0.03).
There are no data on correlations with hip symptoms and
cartilage thickness. Compared to X-ray, femoral head cartilage
volume as measured by MRI was signiﬁcantly correlated with total
hip radiographic JSN (Spearman's rho ¼ 0.24, P < 0.01), superior
JSN (Spearman's rho ¼ e0.18, P < 0.03), and axial JSN (Spearman's
rho ¼ 0.23, P < 0.01)28.
Relatively little data exists for use of parameter mapping in
articular cartilage in OA. T2, T1rho, and dGEMRIC have all been
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comparing these methods with symptoms. There is some evidence
that the dGEMRIC index of the acetabular cartilage may better
predict early joint failure than radiographic measures of hip OA112.
dGEMRIC values have been found to be signiﬁcantly higher in a
control group than in a patient group with different hip joint de-
formities90. A recent study using dGEMRIC showed that lower
dGEMRIC indices (marker for cartilage degeneration) were found at
the superoinferior and superior regions of the femoroacetabular
joint in patients with CAM-type impingement (compared to con-
trols), and were correlated to beta- but not alpha-angles92. Another
study including patients with hip dysplasia showed that the
dGEMRIC indices were globally decreased (in the whole joint) and
not only in speciﬁc locations, supporting that hip OA in acetabular
dysplasia is a biologically event affecting the whole femo-
roacetabular joint88. Other interesting studies showed that
dGEMRIC was capable in mapping the regions of the femo-
roacetabular joints affected by early cartilage degeneration (lower
indices) in patients with femoroacetabular impingement anat-
omy32,113. To our knowledge, no longitudinal studies of hip OA
demonstrated the ability of dGEMRIC indices in predicting cartilage
loss or relevant structural deterioration over time.
Recommendations for clinical trials e hip
Introduction
Recommendations for clinical trials in hip imaging (Table II) will
follow closely the recommendations for the knee, hand, and other
joints. Differences between joints reﬂect differences in anatomy and
technical factors for modalities such as MRI. Because imaging of the
hip joint is not as advanced as that of the knee for MRI, adjustments
need to be made in acquisition techniques for the anatomy, thin
articular cartilage, and depth of the joint. In general, all trials using
hip imaging methods should have a protocol that is tested on vol-
unteers and images should be evaluated prior to implementation.
Radiographic scores e semi-quantitative
As detailed above, a variety of semi-quantitative (subjective)
radiographic scoring systems exist to evaluate hip OA on X-ray.
Most widely used and recommended are KL scores70 and the OARSI
atlas73. These measures are simple to perform, and given the cost
and widespread availability of radiography, are fairly standard in
clinical trials. A recent large study of X-ray grading in hip OA con-
cludes that although KL, OARSI stages and categorization of JSW all
have similar predictive and construct validity, it appears that cat-
egorical JSW is more reproducible and more sensitive to change103.
Radiographic scores e quantitative
For quantitative assessment of hip OA on radiography, standing
JSW measurements are recommended. The JSW is assessed on a
single yearly standing AP plain radiograph of the pelvis or indi-
vidual hip with feet internally rotated 15e2012.
MRI e semi-quantitative scores
For MRI, use of a semi-quantitative scoring system such as
HOAMS, SHOMRI, or HIMRISS is recommended. Use of semi-
quantitative scoring systems has been very successful in the knee
in evaluating disease progression, but has been used in a rather
limited fashion in the hip. Technical factors of hip MRI such as
image resolution and SNR (see above) need to be paid attention to
so as to have sufﬁcient image quality for accurate scoring.MRI e quantitative measurements
Use of quantitative MR endpoints is recommended as a sec-
ondary aim for trials at this point. Volumetric assessment of artic-
ular cartilage has been shown to correlate with X-ray grade of
disease28. Cartilage volume at thickness measurement needs
improved CV for widespread use. Assessment of cartilage compo-
sition parameters such as T1 rho and T2 relaxation times have been
studies in preliminary small cohorts, but limited information on the
relationship to OA progression in the hip exists41,44. dGEMRIC is the
best-studied approach to cartilage composition analysis in the hip
to date32,88,94,95. BMLs can be measured for size and T2 relaxation
time, but limited data also exists here85. Assessment of hip joint
synovitis has been done with contrast-enhanced MRI but not in the
setting of OA114.
Proven reliability in OA clinical trials
Unfortunately limited data exists on reliability of imaging in OA
trials particularly on MRI. Unlike the knee joint, where there are
multiple large studies that have relied on MRI, the hip has not been
well studied. Certainly radiography is recommended, as would be
MRI with semi-quantitative scoring. Assessment with quantitative
MRI has been limited and for some methodologies requires more
research into the sensitivity and speciﬁcity of these methods, as
well as improved reproducibility.
Recommendations for RESEARCH e hip
Recommendations for research (Table III) are included in detail
below. These have been divided into acquisition, processing, and
the need for more studies in hip OA with imaging.
Image acquisition e MRI
Imaging of hip OA is an active area of research. In particular, MRI
will beneﬁt from more work in improved technical factors. Dedi-
cated, multi-channel hip coils will improve SNR from the hip joint
and improve assessment of cartilage. Higher ﬁeld MRI systems can
also improve SNR. Application of more novel imaging methods to
the hip, such as UTE imaging, has the potential to provide more
information on early disease progression. The potential value of
additional compositional techniques for hip joint cartilage assess-
ment such as T2*, diffusion, sodium or GAG-CEST at different ﬁeld
strengths and role in prediction of later outcomes needs to be
explored further.
Post processing software development
Software that allows calculation of thickness maps in the hip,
BML volume, measurement of relaxation parameters such as T2,
T1rho, etc. will be helpful to further enhance quantitative mea-
surements. Many packages exist for this type of analysis for knee
MRI but have not been validated or explored in the hip. Develop-
ment of software for analysis needs to be done in tissues other than
cartilage: bone deformation, BMLs, synovitis, labral deformation
and relaxation properties, etc. Fully automated software develop-
ment will also help in increasing sample size; the more automated
these approaches can be the better for large trials.
More studies of hip OA with imaging are needed
In general, more studies of hip OA using imaging are needed.
Radiography is fairly well studied, with the known limitations of
lack of soft tissue discrimination and low sensitivity to disease
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assessment of potential of these to contribute to trials is lacking.
Ultrasound, for example, may contribute to inﬂammation assess-
ment in the future, and requires further study. Standardization and
validation of MRI acquisition methods would be helpful. To date,
limited information is available on the MRI reproducibility and
sensitivity to change, both in semi-quantitative and quantitative
assessments. Studies of early disease with an increased sample size
are badly needed.
For imaging in clinical trials, validation of reliability and preci-
sion are needed. Development of predictive models would be
helpful. Comparison of OA data with age-matched normal and
radiographic data are critical steps to determine the sensitivity of
the measures. Evaluation of the predictive power of imaging
methods such as MRI in hip OA needs to be done, particularly with
respect of the ability to assess risk of THR and other proven clinical
outcome measures. Correlation of hip imaging results, particularly
MRI, with patient symptoms such as pain, is lacking. Statistical
shape modeling has shown a predictive ability to predict OA
deterioration, but further evaluation of the applicability to clinical
trials is required.
Summary and conclusion
Radiographic measurement of JSW and semi-quantitative
radiographic measures in hip OA have been widely studied and
validated. CT and ultrasound have potential applications in bony
anatomy and inﬂammation, respectively. MRI has been less studied
in the hip than the knee, and need further longitudinal assessment
with respect to acquisition techniques validation, features to assess,
and scores to be used. Clinical trials of the hip joint can certainly
beneﬁt from the addition of imaging such as radiography for semi-
quantitative scoring and assessment of JSW. Other than radiog-
raphy, MRI has the most potential for clinical trials.
MRI has been shown to be potentially useful, and two semi-
quantitative scoring systems are available. Assessment of synovi-
tis and inﬂammation can be performed with MRI. Quantitative
assessment of joint tissues with MRI such as cartilage thickness or
cartilage composition needs further study and validation, but may
be useful for secondary endpoints. Because of the location and
anatomy of the hip joint, MRI requires more attention to technical
factors for adequate image quality. Imaging should be performed at
3 T with dedicated coils when possible. More studies on MRI are
needed to validate quantitative techniques and advance the state-
of-the-art imaging hip OA.
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